Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Journal of Crohn'S & Colitis|November 17, 2018
Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective AnalysisAlissa Walsh, Andrey Kormilitzin, Christopher Hinds, et al.Journal of Crohn'S & Colitis|November 19, 2016
Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative ColitisMarianne Guirgis, Emily Wendt, Lai Mun Wang, et al.European Journal of Immunology|October 14, 2015
Pattern recognition receptor mediated downregulation of microRNA-650 fine-tunes MxA expression in dendritic cells infected with influenza A virusTica Pichulik, Elham Khatamzas, Xiao Liu, et al.Gut|May 20, 2015
Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-upRobert V Bryant, Daniel C Burger, Joseph Delo, et al.Gut|September 28, 2022
Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid responseAlex Adams, Vipin Gupta, Waled Mohsen, et al.The Lancet. Gastroenterology & Hepatology|June 20, 2020
British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitisNick Powell, Hajir Ibraheim, Tim Raine, et al.Nature Medicine|August 5, 2020
Single-cell atlas of colonic CD8<sup>+</sup> T cells in ulcerative colitisDaniele Corridoni, Agne Antanaviciute, Tarun Gupta, et al.Immunity|September 24, 2013
The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 releaseOliver Brain, Benjamin M J Owens, Tica Pichulik, et al.Annals of Gastroenterology|March 5, 2020
Effectiveness and safety of vedolizumab in inflammatory bowel disease patients aged 60 and over: an observational multicenter UK experienceHajir Ibraheim, Mark A Samaan, Ashish Srinivasan, et al.British Journal of Cancer|March 16, 2021
Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profilesWeiyu Ye, Anna Olsson-Brown, Robert A Watson, et al.Pageof 3